Ipswich Investment Management’s Eli Lilly LLY Stock Holding History

Ipswich Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.07M	Buy	6,727 +430	+7%	+$439K	1.7%	17
2026 Q1	$5.79M	Sell	6,297 -762	-11%	-$773K	1.36%	22
2025 Q4	$7.59M	Buy	7,059 +64	+0.9%	+$61.2K	1.76%	13
2025 Q3	$5.34M	Buy	6,995 +1,230	+21%	+$915K	1.25%	24
2025 Q2	$4.49M	Buy	5,765 +1,950	+51%	+$1.52M	1.08%	29
2025 Q1	$3.15M	Sell	3,815 -395	-9%	-$329K	0.78%	36
2024 Q4	$3.25M	Sell	4,210 -14	-0.3%	-$11.6K	0.78%	37
2024 Q3	$3.74M	Sell	4,224 -241	-5%	-$217K	0.87%	35
2024 Q2	$4.04M	Sell	4,465 -262	-6%	-$210K	0.95%	33
2024 Q1	$3.68M	Hold	4,727	–	–	0.86%	36
2023 Q4	$2.76M	Sell	4,727 -150	-3%	-$87.6K	0.7%	44
2023 Q3	$2.62M	Sell	4,877 -365	-7%	-$188K	0.72%	43
2023 Q2	$2.46M	Buy	5,242 +195	+4%	+$81.8K	0.65%	44
2023 Q1	$1.73M	Sell	5,047 -26	-0.5%	-$8.77K	0.47%	60
2022 Q4	$1.86M	Hold	5,073	–	–	0.53%	54
2022 Q3	$1.64M	Sell	5,073 -1,834	-27%	-$581K	0.52%	57
2022 Q2	$2.24M	Hold	6,907	–	–	0.64%	50
2022 Q1	$1.98M	Hold	6,907	–	–	0.49%	60
2021 Q4	$1.91M	Hold	6,907	–	–	0.45%	65
2021 Q3	$1.6M	Hold	6,907	–	–	0.41%	71
2021 Q2	$1.58M	Hold	6,907	–	–	0.41%	69
2021 Q1	$1.29M	Hold	6,907	–	–	0.36%	79
2020 Q4	$1.17M	Sell	6,907 -20	-0.3%	-$2.99K	0.35%	75
2020 Q3	$1.02M	Hold	6,927	–	–	0.33%	71
2020 Q2	$1.14M	Hold	6,927	–	–	0.39%	66
2020 Q1	$961K	Sell	6,927 -1,380	-17%	-$190K	0.38%	65
2019 Q4	$1.09M	Hold	8,307	–	–	0.32%	75
2019 Q3	$929K	Hold	8,307	–	–	0.3%	79
2019 Q2	$920K	Sell	8,307 -50	-0.6%	-$5.89K	0.29%	79
2019 Q1	$1.08M	Sell	8,357 -1,325	-14%	-$161K	0.35%	70
2018 Q4	$1.12M	Buy	9,682 +756	+8%	+$84.5K	0.41%	63
2018 Q3	$958K	Buy	+8,926	New	+$892K	0.32%	74
2018 Q2	–	Sell	-8,936	Closed	-$691K	–	121
2018 Q1	$691K	Buy	8,936 +756	+9%	+$60.9K	0.29%	82
2017 Q4	$691K	Sell	8,180 -100	-1%	-$8.51K	0.29%	82
2017 Q3	$708K	Hold	8,280	–	–	0.32%	79
2017 Q2	$681K	Hold	8,280	–	–	0.32%	75
2017 Q1	$696K	Hold	8,280	–	–	0.3%	75
2016 Q4	$609K	Hold	8,280	–	–	0.28%	78
2016 Q3	$665K	Hold	8,280	–	–	0.33%	72
2016 Q2	$652K	Hold	8,280	–	–	0.32%	71
2016 Q1	$626K	Hold	8,280	–	–	0.3%	70
2015 Q4	$698K	Sell	8,280 -2,275	-22%	-$189K	0.31%	72
2015 Q3	$883K	Buy	10,555 +100	+1%	+$8.44K	0.42%	63
2015 Q2	$873K	Sell	10,455 -200	-2%	-$15.2K	0.39%	63
2015 Q1	$774K	Hold	10,655	–	–	0.34%	66
2014 Q4	$735K	Sell	10,655 -800	-7%	-$54K	0.31%	68
2014 Q3	$743K	Hold	11,455	–	–	0.32%	63
2014 Q2	$713K	Sell	11,455 -1,100	-9%	-$65.6K	0.28%	70
2014 Q1	$739K	Buy	12,555 +3,300	+36%	+$184K	0.32%	66
2013 Q4	$473K	Hold	9,255	–	–	0.2%	92
2013 Q3	$466K	Sell	9,255 -100	-1%	-$5.24K	0.21%	88
2013 Q2	$459K	Buy	+9,355	New	+$509K	0.2%	94

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Ipswich Investment Management's LLY Position: Q2 2026 in Review

Ipswich Investment Management increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $439K and bringing the position to 6,727 shares worth $8.07M. The position accounts for 1.7% of the portfolio, ranked #17.

Ipswich Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 1,251 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ipswich Investment Management held 6,727 shares of Eli Lilly worth $8.07M as of Q2 2026.
Ipswich Investment Management bought 430 Eli Lilly shares in Q2 2026, an estimated $439K.
Eli Lilly made up 1.7% of Ipswich Investment Management's portfolio in Q2 2026, its #17 holding.
Ipswich Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
1,251 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.